Drugs / Donor mesenchymal stem cell infusions
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT02582775 | Mar 2016 → Nov 2022 | epidermolysis bullosa | Masonic Cancer Center, University of Minnesota | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Donor mesenchymal stem cell infusions | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02582775 ↗ |
| Modality | Cell therapy | “serial infusions of donor-derived mesenchymal stromal cells (MSC)” NCT02582775 ↗ |